AMPH Latest Press Releases

-- February 26, 2026 --

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025 ACCESS Newswire 4:05 PM

-- February 24, 2026 --

Amphastar Announces FDA Approval for Ipratropium Bromide HFA ACCESS Newswire 6:00 AM

-- February 20, 2026 --

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 ACCESS Newswire 6:00 AM

-- January 7, 2026 --

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference ACCESS Newswire 6:00 AM

-- December 15, 2025 --

Amphastar Announces FDA Approval for Teriparatide Injection ACCESS Newswire 6:00 AM

-- November 12, 2025 --

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference ACCESS Newswire 6:00 AM

-- November 6, 2025 --

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025 ACCESS Newswire 4:05 PM

-- October 27, 2025 --

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025 ACCESS Newswire 6:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software